NARCOTICS ANALGESICS MARKET ANALYSIS

Market Challenges And Opportunities

Narcotics Analgesics Market – Restraint

Shortages of narcotics analgesics medications is likely to alter the growth of narcotics analgesics market. For instance, according to the Drug Enforcement Administration (DEA) of U.S. February 2018, hospitals and other healthcare providers in U.S. are currently facing critical shortages of a number of injectable opioid medications, including morphine, hydromorphone, and fentanyl. Injectable opioids are critical to treating the pain needs of patients undergoing interventional procedures such as cardiac catheterization and surgeries. Diminished supply of these critical drugs, can lead to less efficient pain control for patients since opioid analgesics are highly potent in pain control.

Narcotics Analgesics Market – Drivers

Increase in the research for narcotics analgesics drugs is projected to rise the growth of global the market during the forecasted period. For instance, a phase III clinical study by Loma Linda University is undergoing for drug Narco. The objective of the study is to evaluate patient pain level in the immediate post-operative period and quantify pain medication usage in patients who undergo outpatient Ear, Nose, and Throat (ENT) surgeries. The study was started in February 2018, and is estimated to complete in January 2019.

Furthermore, Temple University along with AstraZeneca is undergoing clinical phase II study to assess the effect of opioids on esophageal motility. The study found that chronic opioid users are suffering with esophageal motor dysfunctioning. This study will explore the safety and tolerability of MOVANTIK (Naloxegol) and is expected to improve opioid- induced esophageal motility disorders. The study was started in January 2017 and is expected to complete in January 2020.